Sheikh Zayed Federal Postgraduate Medical Institute
Sheikh Zayed Federal Postgraduate Medical Institute
Explore linked clinical trials.5 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Impact of Hypoalbuminemia on Cefoperazone/Sulbactam Induced Coagulopathy in Post-Operative Surgical Patients | Cefoperazone/Sulbactam Induced Coagulopayjy | Not yet recruiting | Not stated | 2026-09-10 | NCT07773584 | |
| Comparison of Effectiveness and Safety of Tofacitinib Versus Upadacitinib as Add-on to Methotrexate in Rheumatoid Arthritis | Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis | Not yet recruiting | Phase 4 | 2026-06-09 | NCT07636057 | |
| Management of Epistaxis Comparing Nasal Packing Versus Greater Palatine Foramen Block | Epistaxis, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, nasal disorder, otorhinolaryngologic disease, respiratory system disorder | Not yet recruiting | Not applicable | 2026-02-24 | NCT07421622 | |
| Comparison of Outcomes Between Topical Minoxidil Versus Oral Minoxidil for the Treatment of Androgenetic Alopecia | Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, alopecia, androgenetic alopecia, disorder of pilosebaceous unit, hypotrichosis, skin disorder | Not yet recruiting | Phase 3 | 2025-12-10 | NCT07273799 | |
| High-Dose Rosuvastatin Preloading for Enhanced Outcomes in STEMI Patients Undergoing Primary PCI | Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, ST-elevation myocardial infarction, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder | Active, not recruiting | Phase 2 | 2025-04-11 | NCT06924684 |